ERIC 2018 | How biomarkers can aid clinical decision making in CLL

Kostas Stamatopoulos

Kostas Stamatopoulos, MD, PhD, of the Center for Research and Technology Hellas, Thessaloniki, Greece, discusses precision medicine and how biomarkers can aid in clinical decision making in chronic lymphocytic leukemia (CLL). This video was recorded at the European Research Initiative on CLL (ERIC) International Meeting 2018, held in Barcelona, Spain.

Share this video